MELBOURNE, Australia, April 28, 2020 (GLOBE NEWSWIRE) — Immuron Limited (ASX: IMC; NASDAQ: IMRN), an Australian biopharmaceutical company focused on […]
900+ decision makers understand the imperatives of digital experience, yet the majority have cancelled or postponed projects; Progress identifies those […]
28 April 2020, 10:30 CETArcelorMittal today announces the publication of its first quarter 2020 EBITDA sell-side analysts’ consensus figures.The consensus […]
Initial translational analysis, EXPLORE, showed overexpression of C5a/C5aR pathway in patients with severe COVID-19Innate Pharma SA (Euronext Paris: IPH – […]